PHOTO
Dubai – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) celebrated International Women’s Day today by hosting guest speakers including Mariam Farag, Group Head of CSR at MBC, and Adela Avecedo, Chair, e7 Daughters of the Emirates program alongside five internal champions of diversity and inclusion.
Representing 16 different nationalities, 44 percent of Takeda’s leadership in the area - India, CIS (the Commonwealth of Independent States), the Middle East including Turkey, and Africa – are women. Overall, ICMEA has a gender mix of 58% women and 42% men.
Under the global theme for 2020 “Each for Equal”, the event saw the celebration of personal success stories, with the guest speakers sharing insights into building an inclusive workplace, highlighting it as a shared responsibility.
-Ends-
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
For more information, visit https://www.takeda.com.
Media Contacts
Yasmeen Al Shyoukh
Yasmeen.Alshyoukh@fleishmaneurope.com
+971503000938
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
